Treatment of Corynebacterium Infections

First-Line Treatment Options

The Centers for Disease Control and Prevention recommends urgent treatment with diphtheria antitoxin (DAT) for Corynebacterium diphtheriae infections, particularly respiratory diphtheria, without waiting for laboratory confirmation 1
Vancomycin is recommended as first-line therapy for severe infections or multidrug-resistant strains 2

The Centers for Disease Control and Prevention advises administering diphtheria antitoxin (DAT) immediately if respiratory diphtheria is suspected, and initiating antibiotic therapy without waiting for culture confirmation 1
For severe infections or suspected resistant strains, vancomycin is the preferred agent 2
Polymyxin-based combination therapy may be considered for multidrug-resistant strains 3, 4

The Centers for Disease Control and Prevention recommends following the same treatment guidelines for C. ulcerans as for C. diphtheriae, and azithromycin has been used successfully in case reports 1
For catheter-related Corynebacterium infections, the Infectious Diseases Society of America recommends removing the catheter when possible, and treating with appropriate systemic antibiotics for 10-14 days 5

The Centers for Disease Control and Prevention emphasizes the critical importance of antitoxin administration to neutralize circulating toxin and prevent life-threatening complications in toxigenic strains producing diphtheria toxin 1
Therapeutic drug monitoring should be considered when using vancomycin or aminoglycosides 6
Combination therapy may be more effective than monotherapy for multidrug-resistant strains 3, 4
In diabetic foot infections where Corynebacterium species are isolated, consider whether they represent true pathogens or colonizers before initiating targeted therapy 7, 8

The Centers for Disease Control and Prevention recommends vaccination with diphtheria toxoid for prevention of disease caused by toxin-producing Corynebacterium species, with adults receiving a diphtheria-toxoid-containing vaccine every 10 years after completing primary childhood vaccination 1
Close contacts of patients with C. diphtheriae should have their vaccination status assessed and updated if necessary 1

Failing to administer diphtheria antitoxin promptly in suspected cases of toxigenic diphtheria can have severe consequences, as emphasized by the Centers for Disease Control and Prevention 1
Misinterpreting Corynebacterium species as contaminants rather than pathogens in appropriate clinical contexts can lead to inadequate treatment, as noted by the Infectious Diseases Society of America 8
Overlooking the need for species identification and toxin production testing can result in inappropriate management, as highlighted by the Centers for Disease Control and Prevention 1